SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-023629
Filing Date
2021-02-16
Accepted
2021-02-16 14:14:03
Documents
1
Group Members
DR. JAMES I. HEALYDR. MAHA KATABIDR. MICHAEL F. POWELLSOFINNOVA MANAGEMENT X, L.L.C.

Document Format Files

Seq Description Document Type Size
1 SC 13D tm216650d3_sc13d.htm SC 13D 107177
  Complete submission text file 0001104659-21-023629.txt   108891
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Subject) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92160 | Film No.: 21636132
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners X, L.P. (Filed by) CIK: 0001680200 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D